Newsgroup: it.economia.borsa
Titolo: CELL T. - AHI AHI accordo segreto...e si devono ricoprire!!!!!

Da un forum USA: 
In sintesi Cell Therapeutics autorizza esplicitamente il Fondo "Enable 
Growth Partners LP " ad effettuare hedging e operazioni short che 
"possono determinare una riduzione del capitale investito dagli 
azionisti" 
... piu' chiaro di così , complimenti Mr Bianco 
Ecco il testo originale 
This Securities Purchase Agreement (this  Agreement ) is dated as of 
September 15, 2008, between Cell Therapeutics, Inc., a Washington 
corporation (the  Company ), and Enable Growth Partners LP ( Enable ). 
(ee) Acknowledgement Regarding Enable s Trading Activity. 
it is understood and acknowledged by the Company 
(i) that Enable has not been asked to agree, nor has Enable agreed, to 
desist from purchasing or selling, long and/or short, securities of the 
Company, or  derivative  securities based on securities issued by the 
Company or to hold the Securities for any specified term; 
(ii) that past or future open market or other transactions by Enable, 
including Short Sales, and specifically including, without limitation, 
Short Sales or  derivative  transactions, before or after the closing of 
this or future transactions, may negatively impact the market price of 
the Company s publicly-traded securities; 
(iii) that Enable, and counter-parties in  derivative  transactions to 
which Enable is a party, directly or indirectly, presently may have a 
 short  position in the Common Stock, and 
(iv) that Enable shall not be deemed to have any affiliation with or 
control over any arm s length counter-party in any  derivative  
transaction. 
The Company further understands and acknowledges that 
(a) Enable may engage in hedging activities at various times during the 
period that the Securities are outstanding, and 
(b) such hedging activities (if any) could reduce the value of the 
existing stockholders  equity interests in the Company at and after the 
time that the hedging activities are being conducted. 
The Company acknowledges that such aforementioned hedging activities do 
not constitute a breach of any of the Transaction Documents. 
============================== 
This Securities Purchase Agreement (this  Agreement ) is dated as of 
September 15, 2008, between Cell Therapeutics, Inc., a Washington 
corporation (the  Company ), and Enable Growth Partners LP ( Enable ). 
Enable Opportunity Partners LP and Pierce Diversified Master Strategy 
Fund LLC, Ena (together, the  Enable Affiliates ) are also parties 
hereto for purposes of Sections 4.13, 4.14 and 4.15. 
Cell Therapeutics Inc · 8-K · For 9/15/08 · EX-10.1 
Filed On 9/17/08 5:25pm ET · SEC File 1-12465 · Accession Number 
1193125-8-197514
-- 
Trader di professione

 azionisti"
Danka...ma quello che scrivi almeno lo leggi o fai solo cut and paste?
Mi spieghi come hai fatto ad arrivare a capire che devono ricoprirsi dopo 
che:
----> hanno autorizzato il fondo GPLP ad effettuare hedging e "OPERAZIONI 
SHORT"?
OPERAZIONI SHORT......hanno autorizzato ad effettuare...OPERAZIONI SHORT.
Inoltre non ha senso paragonare ctic a vw....nel caso della casa 
automobilistica tedesca era semplice e profittevole aprire arbitraggi ---> 
VW short - PSA - RENAULT long.....nel caso di CTIC è talmente alto il 
rischio default che anche costruire arbitraggi usandolo come base per lo 
short è poco saggio.